The global Varicose Vein Treatment Devices Market is estimated to be valued at Us$ 1355.75 Mn in 2023 and is expected to exhibit a CAGR Of 6.5% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
The global Varicose Vein Treatment Devices Market is estimated to be valued at Us$ 1355.75 Mn in 2023 and is expected to exhibit a CAGR Of 6.5% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Varicose vein treatment devices are medical equipment used to treat varicose veins, which are abnormally swollen and twisted veins that are most commonly found in the legs and feet. Key devices used for varicose vein treatment include laser and light devices, radiofrequency devices, and ultrasound guided foam sclerotherapy devices. These devices provide minimally invasive treatment options and help avoid invasive surgeries for varicose vein removal.
Market key trends:
One of the key trends in the varicose vein treatment devices market is the rising adoption of minimally invasive vein treatments. Minimally invasive procedures such as endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) are gaining popularity due to benefits such as reduced pain, fewer complications, and quick recovery time compared to traditional invasive vein stripping surgeries. Also, minimally invasive procedures do not require large incisions or general anesthesia and allow patients to return to normal activities sooner. Further, manufacturers are actively focusing on developing innovative minimally invasive treatment devices such as dual wavelength and 980nm laser systems to improve treatment efficacy and customer experience.
Segment Analysis
The global varicose vein treatment devices market is segmented on the basis of product, end-user, and geography. By product, the market is segmented into ablation devices and sclerotherapy injections. Among these, the ablation devices segment is expected to dominate the market during the forecast period. Ablation devices are more effective than sclerotherapy injections for treating varicose veins. By using minimally invasive techniques such as laser ablation and radiofrequency ablation, they can permanently remove varicose veins. This reduces the risk of recurrence and provides long-lasting results.
Key Takeaways
The Global Varicose Vein Treatment Devices Market Size is expected to witness high growth, exhibiting a CAGR of 6.5% over the forecast period, due to rising incidence of varicose veins and technological advancements in treatment devices.
Regional analysis
North America is expected to dominate the global market during the forecast period. High healthcare expenditure, rising obesity rates leading to varicose veins, and availability of advanced treatment options drive the North America market. Asia Pacific is expected to exhibit the highest growth rate over the forecast period due to growing medical tourism industry and increasing disposable incomes.
Key players
Key players operating in the varicose vein treatment devices market are AngioDynamics, Inc., Syneron Medical Ltd., Dornier Medtech GmbH., Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, WONTECH Co., Ltd., Intros Medical Laser GmbH, and Energist Ltd. Syneron Medical Ltd. and AngioDynamics, Inc. together account for a significant market share.
UpMarketResearch offers a latest published report on “Global Varicose Vein Treatment Devices Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.
The report contains 140 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
According to the report, the global varicose vein treatment market was valued at ~US$ 1.5 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=11714Varicose vein is one of the common diseases caused due to damage to the vein valves.
Endovenous ablation is a less-invasive treatment option for varicose veins.In terms of treatment type, the supportive treatments segment accounted for a major share of the global varicose vein treatment market in 2018.
Moreover, increase in awareness about ablation devices is expected to fuel the growth of the segment.
Based on end user, the hospitals & ambulatory surgical centers segment accounted for a major share of the market, due to the availability of services and rise in the rate of hospitalization.
Moreover, the preference for ambulatory surgical centers due to short hospital stays is likely fuel the growth of the segment.Request COVID Analysis on Varicose Vein Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=11714Global Varicose Vein Treatment Market: Prominent RegionsNorth America held a major share of the global varicose vein treatment market in 2018.
According to the American Heart Association, Inc., the prevalence of reticular vein and spider telangiectasias is higher in women in the U.S. Europe held the second-largest share of the global varicose vein treatment market in 2018.
The global market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.
Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market.
Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.Varicose Vein Treatment Market segmented into :+ On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.
The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.+ Based on type of products, the market is segmented into ablation devices, venous closure products, and surgical products.
The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices.+ This report covers the market across two major geographies, namely, North America and Europe.
In this report, the North American market is further segmented into the U.S. and Canada, while the European market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe.
